Fusion Antibodies

Stand: 28
Founded in 2001, Fusion Antibodies is a leading Contract Research Organisation (CRO) headquartered in Belfast, Northern Ireland. With over two decades of expertise, the company provides a comprehensive suite of antibody development capabilities spanning discovery, development, and supply. Fusion developed proprietary best-in-class platforms such as Optimal' Mammalian Display and AI/ML-ab' for antibody discovery, CDRx' for antibody humanization, RAMP' for affinity maturation, and Ab-ility' for in silico developability assessment. The company's mission is to enable biopharmaceutical and diagnostic organisations to develop innovative products in a timely, cost-effective manner, working as a true extension of client teams to deliver solutions that meet both scientific and commercial goals.
Visit website (opens in a new tab)
Loading
View All (opens in a new tab)

Contact Exhibitor